| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $480.9M | +8.4% |
| Cost of Revenue | $86.3M | -0.2% |
| Gross Profit | $394.7M | +10.4% |
| R&D Expense | $138.1M | -0.8% |
| SG&A Expense | $107.5M | +0.8% |
| Operating Income | -$81.3M | +27.7% |
| Interest Expense | $11.5M | +23.9% |
| Pre-tax Income | -$88.3M | +28.1% |
| Income Tax | $1.6M | +230.1% |
| Net Income | -$89.9M | +27.1% |
| EPS (Basic) | -$0.61 | +27.4% |
| EPS (Diluted) | -$0.61 | +27.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $202.8M | -33.6% |
| Accounts Receivable | $33.7M | +3.6% |
| Current Assets | $263.5M | -26.3% |
| Total Assets | $810.2M | -13.8% |
| Current Liabilities | $290.0M | -2.0% |
| Long-term Debt | $182.9M | -12.8% |
| Total Liabilities | $523.4M | -10.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $8.8M | -84.8% |
| Capital Expenditures | $449K | -38.9% |
| Investing Cash Flow | -$8.7M | +3.9% |
| Financing Cash Flow | -$102.3M | -408.0% |
| Free Cash Flow | $8.4M | -85.4% |
| Stockholders' Equity |
| $286.8M |
| -19.1% |